Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
Phase 2
80
about 5.8 years
2.5–5
2 sites in AZ, NY
What this study is about
This trial is testing a treatment for children with autism spectrum disorder (ASD) who have language problems. The goal is to see if leucovorin calcium improves their language skills and other symptoms associated with ASD.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Levoleucovorin Calcium
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Antidotes, Deterrents, and Toxicologic Agents
injection (Injection)
Secondary: Evaluate change in autism severity of specific symptoms, Evaluate the change in effects of autism symptoms most problematic to family members, Evaluate the change in social withdrawal autism symptoms, Evaluate the change in stereotypical autism symptoms, Evaluate the overall change in core autism symptoms of social communication, Evaluate the safety and tolerability of L-leucovorin calcium in young children with ASD
Psychiatry / Mental Health